Filing Details

Accession Number:
0001209191-11-034848
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-06-15 18:34:55
Reporting Period:
2011-06-14
Filing Date:
2011-06-15
Accepted Time:
2011-06-15 18:34:55
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1087432 Intermune Inc ITMN Pharmaceutical Preparations (2834) 943296648
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1303832 Allan Howard Simon 3280 Bayshore Boulevard
Brisbane CA 94005
Svp-Human Resources No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2011-06-14 16,665 $8.73 44,966 No 4 M Direct
Common Stock Acquisiton 2011-06-14 365 $15.34 45,331 No 4 M Direct
Common Stock Disposition 2011-06-14 21,213 $33.00 24,118 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2011-06-14 16,665 $0.00 16,665 $8.73
Common Stock Stock Option (Right to Buy) Disposition 2011-06-14 365 $0.00 365 $15.34
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
33,335 2017-06-08 No 4 M Direct
4,011 2015-05-13 No 4 M Direct
Footnotes
  1. 33.3334% of the total number of shares subject to the stock option vest and become exercisable cumulatively on each of the following dates: June 8, 2011, December 8, 2011 and June 8, 2012.
  2. 25% of the shares subject to the option vest and become exercisable on May 13, 2009, and 1/36th of the shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on May 13, 2012.